Lung Cancer News

Low-dose, volume-based CT screening appeared associated with reduced lung cancer mortality compared with no screening among individuals at high risk for the disease, according to results of the randomized NELSON trial published in The New England Journal of Medicine.

Karen L. Reckamp, MD, MS, has been named director of the division of medical oncology at Cedars-Sinai Cancer.

In 2014, CVS Health said it would stop selling tobacco products, suggesting that such sales contradicted the company’s goal of promoting health.

A randomized phase 3 trial designed to evaluate the addition of tislelizumab to first-line chemotherapy for patients with squamous non-small cell lung cancer met its primary endpoint of PFS, according to results of an interim analysis released by the agent’s manufacturer.

The investigational therapy pralsetinib appeared effective and safe for patients with RET fusion-positive non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

John Theurer Cancer Center at Hacksensack University Cancer Center announced the appointment of five physicians to its medical staff.

High baseline BMI appeared to be independently associated with improved survival among patients with non-small cell lung cancer who received atezolizumab, according to results of a retrospective study published in JAMA Oncology.

The FDA granted priority review to the combination of nivolumab plus ipilimumab for the first-line treatment of patients with metastatic or recurrent non-small cell lung cancer without EGFR or ALK mutations, according to a press release from the agents’ manufacturer.

The addition of pembrolizumab to first-line chemotherapy extended PFS but failed to significantly extend OS among patients with extensive-stage small cell lung cancer, according to topline data released by the agent’s manufacturer.

Cancer mortality rates dropped by 29% between 1991 and 2017 in the United States, with a 2.2% drop between 2016 and 2017, according to according to data from Cancer Statistics 2020, American Cancer Society’s annual report on cancer rates and trends.